Thompson Rahsaan
SEC CIK 1788524 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Chief Legal, Compliance, Sec | 37.6K | — | $1.19M | 8 | 2025-06-21 | 2026-08-14 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-17 16:32 | 2026-08-14 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.13 | -42.7K | 37.6K | -53% | -$474.8K |
| DT | 2026-06-23 16:16 | 2026-06-21 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance | M - OptEx | — | +66.7K | 114.8K | +139% | — |
| DT | 2026-06-23 16:16 | 2026-06-22 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance | S - Sale+OE | $12.68 | -34.6K | 80.2K | -30% | -$438.3K |
| T | 2026-05-13 16:32 | 2026-05-11 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.30 | -1,794 | 48.1K | -4% | -$20.3K |
| D | 2026-02-02 | 2026-01-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance, Sec | S - Sale+OE | $8.83 | -4,080 | 49.9K | -8% | -$36.0K |
| D | 2026-02-02 | 2026-01-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance, Sec | M - OptEx | — | +11.3K | 54.0K | +27% | — |
| 2025-06-30 | 2025-06-26 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance, Sec | S - Sale | $9.21 | -24.0K | 42.7K | -36% | -$221.0K | |
| D | 2025-06-24 | 2025-06-21 | ZVRA | ZEVRA THERAPEUTICS, INC. | Thompson Rahsaan | Chief Legal, Compliance, Sec | M - OptEx | — | +66.7K | 66.7K | New | — |
Purchase Sale Sale after option exercise All abbreviations